Buy & Sell Davita Inc (DVA) – Davita Inc Price Today
Aura AI Summary
Key Stats
- $12.81BMarket Cap
- HealthSector
- -7.78%3M Drawdown
- $25.36BEnterprise Value
- -Dividend Yield
- 100% Buy | 0% SellTrading Activity
- 101 daysTypical Hold Time
Davita Inc (DVA) is currently valued at a market capitalization of $12.81B, with an enterprise value of $25.36B. Over the past 52 weeks, Davita Inc has traded between a low of $103.87 and a high of $200.54, highlighting its annual price range. Over the past three months, Davita Inc has recorded a drawdown of -7.78%, reflecting recent price volatility. On average, investors hold Davita Inc for approximately 101 days, indicating typical investor behavior on the platform.
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Most Recent News
Law firm probes fairness of major energy and tech mergers for shareholders.
Halper Sadeh LLC is investigating whether shareholders of LiveRamp, Dominion Energy, Sachem Capital, and NextEra Energy are receiving fair deals in their companies' recent mergers and acquisitions. The firm suspects insiders may gain financial benefi...
Bill Ackman's sale of Alphabet shares cost $641M; Microsoft bet offsets some losses but not all.
In Q1 2026, Bill Ackman sold 95% of his Alphabet shares, missing out on $641 million in gains as the stock surged. He shifted his investment to Microsoft, which gained $271.8 million since the end of the quarter, partially offsetting the losses. Ackm...
Keysight beats Q2 earnings and revenue estimates, shares jump 8.6%.
Keysight Technologies reported record Q2 earnings of $2.87 per share, surpassing analyst estimates by nearly 24%, with revenue rising to $1.72 billion, up from $1.31 billion last year. CEO Satish Dhanasekaran highlighted the company's strongest quart...
